Recommendations for Assessment of Donor Suitability and Blood and Blood Product Safety in Cases of Possible Exposure to Anthrax: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 17, 2001
June 13, 2024
3c6a09c1-24ab-442b-b40a-2ab825c7ee4a
Related Documents
Validation of Procedures for Processing of Human Tissues Intended for Transplantation: Guidance for Industry
Guidance DocumentMarch 8, 2002Center for Biologics Evaluation and Research
Recommendations for Obtaining a Labeling Claim for Communicable Disease Donor Screening Tests Using Cadaveric Blood Specimens from Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps): Guidance for Industry
Guidance DocumentNovember 1, 2004Center for Biologics Evaluation and Research
Biological Product Deviation Reporting for Blood and Plasma Establishments: Guidance for Industry
Guidance DocumentMarch 12, 2020Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.